+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diabetes Assays - Medical Devices Pipeline Assessment, 2020

  • ID: 5230882
  • Report
  • December 2020
  • Region: Global
  • 75 pages
  • GlobalData

FEATURED COMPANIES

  • Abcodia Ltd
  • Caprion Biosciences Inc
  • FibroStatin SL
  • L2 Diagnostics LLC
  • QuickCheck Health Inc
  • University of Colorado
Summary

The publisher's Medical Devices sector report, “Diabetes Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Diabetes Assays pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Diabetes assay are used to measure glucose levels in patient’s sample. This segment comprises of C-peptide assays, glycated hemoglobin (HbA1c) Assays, Insulin assays and other diabetes assays.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Diabetes Assays under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Diabetes Assays and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Diabetes Assays under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abcodia Ltd
  • Caprion Biosciences Inc
  • FibroStatin SL
  • L2 Diagnostics LLC
  • QuickCheck Health Inc
  • University of Colorado
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Diabetes Assays Overview

3 Products under Development
3.1 Diabetes Assays - Pipeline Products by Stage of Development
3.2 Diabetes Assays - Pipeline Products by Segment
3.3 Diabetes Assays - Pipeline Products by Territory
3.4 Diabetes Assays - Pipeline Products by Regulatory Path
3.5 Diabetes Assays - Pipeline Products by Estimated Approval Date

4 Diabetes Assays - Pipeline Products under Development by Companies
4.1 Diabetes Assays Companies - Pipeline Products by Stage of Development
4.2 Diabetes Assays - Pipeline Products by Stage of Development

5 Diabetes Assays Companies and Product Overview
5.1 Abcodia Ltd Company Overview
5.1.1 Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adaptive Biotechnologies Corp Company Overview
5.2.1 Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 Adipomics Inc Company Overview
5.3.1 Adipomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 ADiTx Therapeutics Inc Company Overview
5.4.1 ADiTx Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Alfa Wassermann Inc Company Overview
5.5.1 Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 AmideBio LLC Company Overview
5.6.1 AmideBio LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 Aura Biotechnologies Pvt Ltd Company Overview
5.7.1 Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Beckman Coulter Inc Company Overview
5.8.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Biocrates Life Sciences AG Company Overview
5.9.1 Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
5.10 BioDesign Institute at Arizona State University Company Overview
5.10.1 BioDesign Institute at Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
5.11 Caprion Biosciences Inc Company Overview
5.11.1 Caprion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Confer Health Inc Company Overview
5.12.1 Confer Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 DaekiTech Company Overview
5.13.1 DaekiTech Pipeline Products & Ongoing Clinical Trials Overview
5.14 Drexel University Company Overview
5.14.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview
5.15 ELITechGroup Inc Company Overview
5.15.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Enable Biosciences Inc Company Overview
5.16.1 Enable Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 FibroStatin SL Company Overview
5.17.1 FibroStatin SL Pipeline Products & Ongoing Clinical Trials Overview
5.18 Fujirebio Diagnostics Inc Company Overview
5.18.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Genesis Detection Systems, Inc. Company Overview
5.19.1 Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.20 Helmholtz Centre for Infection Research Company Overview
5.20.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview
5.21 Hemex Health Inc Company Overview
5.21.1 Hemex Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 IntraMed Diagnostics, LLC Company Overview
5.22.1 IntraMed Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.23 Janssen Diagnostics LLC Company Overview
5.23.1 Janssen Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.24 Johns Hopkins University Company Overview
5.24.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.25 L2 Diagnostics LLC Company Overview
5.25.1 L2 Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.26 Mellitus LLC Company Overview
5.26.1 Mellitus LLC Pipeline Products & Ongoing Clinical Trials Overview
5.27 Numares AG Company Overview
5.27.1 Numares AG Pipeline Products & Ongoing Clinical Trials Overview
5.28 Ortho-Clinical Diagnostics Inc Company Overview
5.28.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 Peri Rx Inc Company Overview
5.29.1 Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 PortaScience Inc Company Overview
5.30.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 Protagen AG Company Overview
5.31.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
5.32 Queen Mary University of London Company Overview
5.32.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
5.33 QuickCheck Health Inc Company Overview
5.33.1 QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Sebia SA Company Overview
5.34.1 Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
5.35 Singulex Inc Company Overview
5.35.1 Singulex Inc Pipeline Products & Ongoing Clinical Trials Overview
5.36 SomaLogic Inc Company Overview
5.36.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.37 The Forsyth Institute Company Overview
5.37.1 The Forsyth Institute Pipeline Products & Ongoing Clinical Trials Overview
5.38 University of Canterbury Company Overview
5.38.1 University of Canterbury Pipeline Products & Ongoing Clinical Trials Overview
5.39 University of Colorado Company Overview
5.39.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.40 University of Florida Company Overview
5.40.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of Oxford Company Overview
5.41.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
5.42 University of South Florida Company Overview
5.42.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.43 University of Strathclyde Company Overview
5.43.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
5.44 Xhale Inc Company Overview
5.44.1 Xhale Inc Pipeline Products & Ongoing Clinical Trials Overview
5.45 Yaathum Biotech Pvt Ltd Company Overview
5.45.1 Yaathum Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Appendix
6.1 Methodology
6.2 About the Publisher
6.3 Contact
6.4 Disclaimer

List of Tables
Table 1: Diabetes Assays - Pipeline Products by Stage of Development
Table 2: Diabetes Assays - Pipeline Products by Segment
Table 3: Diabetes Assays - Pipeline Products by Territory
Table 4: Diabetes Assays - Pipeline Products by Regulatory Path
Table 5: Diabetes Assays - Pipeline Products by Estimated Approval Date
Table 6: Diabetes Assays Companies - Pipeline Products by Stage of Development
Table 7: Diabetes Assays - Pipeline Products by Stage of Development
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Molecular Biomarker - Diabetes - Product Status
Table 10: Molecular Biomarker - Diabetes - Product Description
Table 11: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Status
Table 13: Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Description
Table 14: Adipomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Diagnostic Test - Gestational Pre-Diabetes - Product Status
Table 16: Diagnostic Test - Gestational Pre-Diabetes - Product Description
Table 17: ADiTx Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: AditxtScore Assay - Type I Diabetes - Product Status
Table 19: AditxtScore Assay - Type I Diabetes - Product Description
Table 20: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: ACE Alera Clinical Chemistry System - Direct A1c Assay - Product Status
Table 22: ACE Alera Clinical Chemistry System - Direct A1c Assay - Product Description
Table 23: AmideBio LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Diagnostic Test - T1 Diabetes - Product Status
Table 25: Diagnostic Test - T1 Diabetes - Product Description
Table 26: Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 27: AURA Quant Glargine ELISA Kit - Product Status
Table 28: AURA Quant Glargine ELISA Kit - Product Description
Table 29: AURA Quant Human C-peptide Kit - Product Status
Table 30: AURA Quant Human C-peptide Kit - Product Description
Table 31: AURA Quant Human Insulin ELISA Kit - Product Status
Table 32: AURA Quant Human Insulin ELISA Kit - Product Description
Table 33: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: AU480 Clinical System - Next Generation HbA1c Assay - Product Status
Table 35: AU480 Clinical System - Next Generation HbA1c Assay - Product Description
Table 36: AU5810 Clinical System - Next-generation HbA1c Assay - Product Status
Table 37: AU5810 Clinical System - Next-generation HbA1c Assay - Product Description
Table 38: AU5820 Clinical System - Next-generation HbA1c Assay - Product Status
Table 39: AU5820 Clinical System - Next-generation HbA1c Assay - Product Description
Table 40: AU5830 Clinical System - Next-generation HbA1c Assay - Product Status
Table 41: AU5830 Clinical System - Next-generation HbA1c Assay - Product Description
Table 42: AU5840 Clinical System - Next-generation HbA1c Assay - Product Status
Table 43: AU5840 Clinical System - Next-generation HbA1c Assay - Product Description
Table 44: AU680 Clinical System - Next-generation HbA1c Assay - Product Status
Table 45: AU680 Clinical System - Next-generation HbA1c Assay - Product Description
Table 46: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Diagnostic Assay - Type 2 Diabetes - Product Status
Table 48: Diagnostic Assay - Type 2 Diabetes - Product Description
Table 49: BioDesign Institute at Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Biomarker Test - Type 1 Diabetes - Product Status

List of Figures
Figure 1: Diabetes Assays - Pipeline Products by Stage of Development
Figure 2: Diabetes Assays - Pipeline Products by Segment
Figure 3: Diabetes Assays - Pipeline Products by Territory
Figure 4: Diabetes Assays - Pipeline Products by Regulatory Path
Figure 5: Diabetes Assays - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
  • Abcodia Ltd
  • Adaptive Biotechnologies Corp
  • Adipomics Inc
  • ADiTx Therapeutics Inc
  • Alfa Wassermann Inc
  • AmideBio LLC
  • Aura Biotechnologies Pvt Ltd
  • Beckman Coulter Inc
  • Biocrates Life Sciences AG
  • BioDesign Institute at Arizona State University
  • Caprion Biosciences Inc
  • Confer Health Inc
  • DaekiTech
  • Drexel University
  • ELITechGroup Inc
  • Enable Biosciences Inc
  • FibroStatin SL
  • Fujirebio Diagnostics Inc
  • Genesis Detection Systems, Inc.
  • Helmholtz Centre for Infection Research
  • Hemex Health Inc
  • IntraMed Diagnostics, LLC
  • Janssen Diagnostics LLC
  • Johns Hopkins University
  • L2 Diagnostics LLC
  • Mellitus LLC
  • Numares AG
  • Ortho-Clinical Diagnostics Inc
  • Peri Rx Inc
  • PortaScience Inc
  • Protagen AG
  • Queen Mary University of London
  • QuickCheck Health Inc
  • Sebia SA
  • Singulex Inc
  • SomaLogic Inc
  • The Forsyth Institute
  • University of Canterbury
  • University of Colorado
  • University of Florida
  • University of Oxford
  • University of South Florida
  • University of Strathclyde
  • Xhale Inc
  • Yaathum Biotech Pvt Ltd
Note: Product cover images may vary from those shown
Adroll
adroll